financetom
Business
financetom
/
Business
/
--Apple to Launch 10th Generation of Apple Watch, Dubbed Apple Watch Series 10
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Apple to Launch 10th Generation of Apple Watch, Dubbed Apple Watch Series 10
Sep 9, 2024 8:58 PM

01:07 PM EDT, 09/09/2024 (MT Newswires) --

Price: 220.45, Change: -0.37, Percent Change: -0.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer Stocks Advance Premarket Friday
Sector Update: Consumer Stocks Advance Premarket Friday
May 31, 2024
09:19 AM EDT, 05/31/2024 (MT Newswires) -- Consumer stocks were advancing premarket Friday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was up 0.2% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was marginally higher. Nordstrom ( JWN ) fell by more than 1% after it reported a fiscal Q1 adjusted net loss of...
Johnson & Johnson Closes Acquisition of Shockwave Medical
Johnson & Johnson Closes Acquisition of Shockwave Medical
May 31, 2024
09:26 AM EDT, 05/31/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that it has closed its acquisition of Shockwave Medical, which it said will operate as a business unit within Johnson & Johnson MedTech. The transaction is anticipated to dilute adjusted earnings per share by about $0.10 in 2024 and $0.17 in 2025 considering the impact...
Nvidia Isn't the Only Way to Play AI
Nvidia Isn't the Only Way to Play AI
May 31, 2024
09:23 AM EDT, 05/31/2024 (MT Newswires) -- Nvidia ( NVDA ) remains the dominant play in AI in the near-term, but there are other ways to play the AI story, according to The Compound and Friends podcast on Friday morning. Host Josh Brown says Nvidia ( NVDA ) will become larger than Apple ( AAPL ) on a market...
Novartis Says Late-Stage Scemblix Trial Meets Primary Endpoints
Novartis Says Late-Stage Scemblix Trial Meets Primary Endpoints
May 31, 2024
09:23 AM EDT, 05/31/2024 (MT Newswires) -- Novartis ( NVS ) said Friday that the late-stage trial for its treatment for chronic myeloid leukemia, Scemblix, has met both of its primary endpoints. Scemblix demonstrated clinically significant efficacy that was better than select standard-of-care therapies of the same type, the drugmaker said. The drug's safety profile was consistent with previous studies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved